I think that’s a bit harsh, three years from now stage 1 should be at nameplate or above and stage 2 funded/started. The lithium supply picture is one of demand overwhelming supply 3-5 years from now which could change the complexion of things greatly. Can you back up your numbers with some justification? As above we’re within touching distance of $70m to $100m annual EBITDA, possibly a couple of quarters to shore that up. Any reasonable PE puts us far north of where we currently are.
- Forums
- ASX - By Stock
- 1MC
- Ann: Completion of Heavily Oversubscribed SPP
Ann: Completion of Heavily Oversubscribed SPP, page-118
Featured News
Add 1MC (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $8.364M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.9¢ | $18.26K | 608.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 180223 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 374484 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 180223 | 0.030 |
2 | 677166 | 0.029 |
3 | 92565 | 0.028 |
1 | 61938 | 0.027 |
1 | 37074 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 374484 | 6 |
0.032 | 92168 | 2 |
0.033 | 378549 | 3 |
0.035 | 200000 | 1 |
0.036 | 12000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
1MC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online